期刊
NATURE BIOTECHNOLOGY
卷 27, 期 10, 页码 925-U88出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.1564
关键词
-
资金
- board of governors for City of Hope Medical Center
- Harry Lloyd Charitable Trust
- Keck Foundation
- National Institutes of Health [R01CA122976, R01CA115815, R01CA115674, P50CA107399]
Efficient delivery of small interfering (si)RNA to specific cell populations in vivo remains a formidable challenge to its successful therapeutic application. We show that siRNA synthetically linked to a CpG oligonucleotide agonist of toll-like receptor (TLR)9 targets and silences genes in TLR9(+) myeloid cells and B cells, both of which are key components of the tumor microenvironment. When a CpG-conjugated siRNA that targets the immune suppressor gene Stat3 is injected in mice either locally at the tumor site or intravenously, it enters tumor-associated dendritic cells, macrophages and B cells. Silencing of Stat3 leads to activation of tumor-associated immune cells and ultimately to potent antitumor immune responses. Our findings demonstrate the potential of TLR agonist-siRNA conjugates for targeted gene silencing coupled with TLR stimulation and immune activation in the tumor microenvironment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据